Probiodrug AG | |
Stock Exchange | Euronext - Alternext Amsterdam |
EPS |
EUR0.95 |
Market Cap |
EUR23.41 M |
Shares Outstanding |
8.19 M |
Public Float |
4.72 M |
Probiodrug AG | |
Stock Exchange | Frankfurt Stock Exchange |
EPS |
EUR0.94 |
Market Cap |
EUR44.21 M |
Shares Outstanding |
8.21 M |
Public Float |
- |
Address |
Weinbergweg 22 Halle Sachsen-Anhalt 06120 Germany |
Employees | - |
Website | http://www.probiodrug.de |
Updated | 07/08/2019 |
Probiodrug AG is a biopharmaceutical company, which engages in the research and development of therapeutic products for the treatment of Alzheimer's disease. Its product pipeline includes PQ912, PBD-C06, and PQ1565. The company was founded by Hans-Ulrich Demuth and Konrad Glund on July 25, 1997 and is headquartered in Halle, Germany. |